Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Itron, Inc. (ITRI) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Itron, Inc. (ITRI) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 8th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 8th:
Halyard Health, Inc. : This medical technology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 6.5% over the last 60 days.
Halyard Health, Inc. Price and Consensus
Halyard Health, Inc. Price and Consensus | Halyard Health, Inc. Quote
Halyard Health's shares gained 8.1% over the last one month higher than S&P 500’s gains of 2.3%. The company possesses a Momentum Score of A.
Halyard Health, Inc. Price
Halyard Health, Inc. Price | Halyard Health, Inc. Quote
Itron, Inc. (ITRI - Free Report) : This metering solutions providerhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Itron, Inc. Price and Consensus
Itron, Inc. Price and Consensus | Itron, Inc. Quote
Itron’s shares gained 6.8% over the last one month. The company possesses a Momentum Score of A.
Itron, Inc. Price
Itron, Inc. Price | Itron, Inc. Quote
LeMaitre Vascular, Inc. (LMAT - Free Report) : This medical devices designer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 12.9% over the last 60 days.
LeMaitre Vascular, Inc. Price and Consensus
LeMaitre Vascular, Inc. Price and Consensus | LeMaitre Vascular, Inc. Quote
LeMaitre Vascular's shares gained 6.1% over the last one month. The company possesses a Momentum Score of A.
LeMaitre Vascular, Inc. Price
LeMaitre Vascular, Inc. Price | LeMaitre Vascular, Inc. Quote
Nova Measuring Instruments Ltd. (NVMI - Free Report) : This process control systems developer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Nova Measuring Instruments Ltd. Price and Consensus
Nova Measuring Instruments Ltd. Price and Consensus | Nova Measuring Instruments Ltd. Quote
Nova Measuring Instruments’ shares gained 7.6% over the last one month. The company possesses a Momentum Score of A.
Nova Measuring Instruments Ltd. Price
Nova Measuring Instruments Ltd. Price | Nova Measuring Instruments Ltd. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we're mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold...
By last year, it was already generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. See Zacks' Top 3 Stocks to Ride This Space >>